|
MID2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72700000025772E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.608400E-04 |
| Normal-vs-Stage2 |
8.023600E-04 |
| Normal-vs-Stage3 |
2.46349995958184E-09 |
| Normal-vs-Stage4 |
1.40160000272616E-08 |
| Stage1-vs-Stage2 |
1.902630E-01 |
| Stage1-vs-Stage3 |
9.89399999999918E-05 |
| Stage1-vs-Stage4 |
7.78960000000772E-05 |
| Stage2-vs-Stage3 |
3.078400E-01 |
| Stage2-vs-Stage4 |
1.626390E-01 |
| Stage3-vs-Stage4 |
5.543800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14100000003781E-06 |
| Normal-vs-AfricanAmerican |
1.59579999992054E-07 |
| Normal-vs-Asian |
1.488440E-01 |
| Caucasian-vs-AfricanAmerican |
7.416100E-02 |
| Caucasian-vs-Asian |
7.533200E-01 |
| AfricanAmerican-vs-Asian |
2.743200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39289999931702E-08 |
| Normal-vs-Female |
1.777980E-04 |
| Male-vs-Female |
5.661900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.99679999999658E-05 |
| Normal-vs-Age(41-60Yrs) |
5.73339999999645E-05 |
| Normal-vs-Age(61-80Yrs) |
1.80390000048547E-07 |
| Normal-vs-Age(81-100Yrs) |
1.283410E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.893630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.030400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.560400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.519800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.676200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.884200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.287800E-01 |
| Normal-vs-Grade 2 |
2.263300E-03 |
| Normal-vs-Grade 3 |
2.86390000603376E-09 |
| Normal-vs-Grade 4 |
2.47330045333172E-10 |
| Grade 1-vs-Grade 2 |
1.156580E-01 |
| Grade 1-vs-Grade 3 |
2.459700E-03 |
| Grade 1-vs-Grade 4 |
3.591500E-04 |
| Grade 2-vs-Grade 3 |
1.373980E-04 |
| Grade 2-vs-Grade 4 |
7.3585000004428E-07 |
| Grade 3-vs-Grade 4 |
2.270200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.950120E-02 |
| Normal-vs-ccB subtype |
3.59910001801467E-09 |
| ccA subtype-vs-ccB subtype |
9.3815000001829E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67014999999937E-05 |
| Normal-vs-N1 |
6.83809999957319E-07 |
| N0-vs-N1 |
7.323500E-03 |
|
|
